Guanhao Biotech Co Ltd (300238) - Total Liabilities
Based on the latest financial reports, Guanhao Biotech Co Ltd (300238) has total liabilities worth CN¥292.32 Million CNY (≈ $42.77 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore 300238 shareholders equity momentum to track the company's year-over-year net asset growth rate.
Guanhao Biotech Co Ltd - Total Liabilities Trend (2007–2025)
This chart illustrates how Guanhao Biotech Co Ltd's total liabilities have evolved over time, based on quarterly financial data. See free cash flow generation of Guanhao Biotech Co Ltd to measure how efficiently the company converts operating cash flow to free cash.
Guanhao Biotech Co Ltd Competitors by Total Liabilities
The table below lists competitors of Guanhao Biotech Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Voneseals Technology (Shanghai) Inc. A
SHE:301161
|
China | CN¥325.99 Million |
|
Zhejiang Risun Intelligent Technology Co. Ltd. A
SHG:688215
|
China | CN¥668.20 Million |
|
Guangdong Tecsun Science & Technology Co Ltd
SHE:002908
|
China | CN¥326.84 Million |
|
Beijing Hanyi Innovation Technology Co. Ltd. A
SHE:301270
|
China | CN¥191.34 Million |
|
BOE Tech Group
SHE:200725
|
China | HK$227.24 Billion |
|
Napatech A/S
OL:NAPA
|
Norway | Nkr59.29 Million |
|
Gladstone Capital Corporation
NASDAQ:GLAD
|
USA | $442.46 Million |
|
Zhejiang Wandekai Fluid Equipment Technology Co. Ltd. A
SHE:301309
|
China | CN¥183.63 Million |
Liability Composition Analysis (2007–2025)
This chart breaks down Guanhao Biotech Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see 300238 market cap.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.00 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.50 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.37 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Guanhao Biotech Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Guanhao Biotech Co Ltd (2007–2025)
The table below shows the annual total liabilities of Guanhao Biotech Co Ltd from 2007 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | CN¥300.50 Million ≈ $43.97 Million |
+4.78% |
| 2024-12-31 | CN¥286.81 Million ≈ $41.97 Million |
+29.00% |
| 2023-12-31 | CN¥222.33 Million ≈ $32.53 Million |
-7.10% |
| 2022-12-31 | CN¥239.33 Million ≈ $35.02 Million |
-31.73% |
| 2021-12-31 | CN¥350.58 Million ≈ $51.30 Million |
-16.14% |
| 2020-12-31 | CN¥418.07 Million ≈ $61.18 Million |
-6.10% |
| 2019-12-31 | CN¥445.21 Million ≈ $65.15 Million |
-7.93% |
| 2018-12-31 | CN¥483.57 Million ≈ $70.76 Million |
-4.29% |
| 2017-12-31 | CN¥505.25 Million ≈ $73.93 Million |
+118.79% |
| 2016-12-31 | CN¥230.93 Million ≈ $33.79 Million |
+23.89% |
| 2015-12-31 | CN¥186.41 Million ≈ $27.28 Million |
+112.01% |
| 2014-12-31 | CN¥87.92 Million ≈ $12.87 Million |
+18.24% |
| 2013-12-31 | CN¥74.36 Million ≈ $10.88 Million |
-15.39% |
| 2012-12-31 | CN¥87.88 Million ≈ $12.86 Million |
+38.90% |
| 2011-12-31 | CN¥63.27 Million ≈ $9.26 Million |
-30.49% |
| 2010-12-31 | CN¥91.03 Million ≈ $13.32 Million |
+100.75% |
| 2009-12-31 | CN¥45.34 Million ≈ $6.64 Million |
+82.78% |
| 2008-12-31 | CN¥24.81 Million ≈ $3.63 Million |
+23.85% |
| 2007-12-31 | CN¥20.03 Million ≈ $2.93 Million |
-- |
About Guanhao Biotech Co Ltd
Guanhao Biotech Co.,Ltd. develops, manufactures, and sells regenerative medicines and life sciences products in China. It offers NormalGEN and GrandNeuro, both a dura repair patch; ThormalGEN, a surgical patch; DermalGEN, a wound dressing product; IREAL breast patch; and Youvision corneal graft, as well as license in intraocular lenses. The company also provides Biological dura, a spinal patch; T… Read more